PODCAST | A Deep-dive into Takeda’s AI Foundations – With Head of Data Steve Winawer

episode

CDO Magazine Podcast Series not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

A.I. Safety Goes Mainstream + a ‘Hard Fork’ Exit AMA 1h 25m · 18 Sep 2026 · Hard Fork

Layoffs at the Kansas City Star will hurt local communities 15 min · 18 Sep 2026 · Kansas City Today

AWP: Beyond the Exam Room: Purpose, Myopia, and Population Health 54 min · 17 Sep 2026 · EyeCode Media

Planning Commission Meeting - Sep 17, 2026 1h 11m · 17 Sep 2026 · Leesburg Planning Commission

Heritage Commission - Sep 14, 2026 1h 57m · 17 Sep 2026 · Loudoun County Board Committees and Advisory Boards

Historic District Review Committee - Sep 14, 2026 1h 36m · 17 Sep 2026 · Loudoun County Board Committees and Advisory Boards

Report any issue

Source

Recorded28 Aug 2025

Publishermedia.rss.com ↗

Handlerec:9998236

Show notes

Takeda Pharmaceutical Company is one of the world’s largest biopharmaceutical firms, known for its science-driven innovation. In this CDO Magazine interview, Steve Winawer, Head of Data, Digital, and Technology for the US Business Unit, speaks with Dave McEachern, Managing Director at AHEAD, about how Takeda ensures data trust, quality, and compliance before diving into AI solutions.You’ll learn:✅Why AI projects start with the right business problem✅How Takeda adapts to 22 unique US state privacy laws✅The company’s evolving approach to digital data and automationThis is Part 1 of a two-part series. Listen now and explore the blueprint for trusted AI in pharma.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in